Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy?
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Association for the Study of Intestinal Diseases
2017-07-01
|
Series: | Intestinal Research |
Online Access: | https://doi.org/10.5217/ir.2017.15.3.263 |